Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Lynx Analytics Unveils LynxKite 2000:MM - The Next Generation of GPU-Optimized Graph AI 2025-03-19 21:00
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH 2025-03-19 19:00
DarwinHealth Recognized and Honored as One of the Top 10 Most Innovative Biotech Companies: Named to Fast Company's Prestigious Annual List of the World's Most Innovative Companies of 2025 2025-03-19 05:45
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC 2025-03-18 21:00
Medit Launches a New All-on-X Solution, Medit SmartX 2025-03-18 15:00
A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™ 2025-03-18 11:00
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America 2025-03-18 06:52
Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia 2025-03-17 19:00
AIM Vaccine reported a significant reduction in losses for 2024, with several major products set to launch that are expected to drive substantial revenue growth 2025-03-17 14:30
HanAll Biopharma Announces Orphan Drug Designation for Batoclimab in Japan for Active Thyroid Eye Disease 2025-03-17 07:59
Skyhawk Therapeutics Presents at Huntington's Disease Youth Organization HDYO International Congress 2025 2025-03-15 18:07
Telix Adds Lead-212 Isotope Production Capability 2025-03-13 06:48
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership 2025-03-12 17:00
SPRIM Global Investments and OneIM Announce $300mn Joint Venture to Accelerate Clinical Trial Financing 2025-03-10 20:19
Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) Approved for Marketing in Second Indication by NMPA for EGFRm NSCLC 2025-03-10 19:22
Everest Medicines Announces First Patient Dosed with EVM16, Its First Internally Developed Personalized mRNA Cancer Vaccine 2025-03-06 16:30
Newly-formed Archerfish Precision Diagnostics Pte Ltd: Ushers a New Era in Advanced Diagnostics 2025-03-06 11:52
Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients 2025-03-05 22:45
Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director 2025-03-05 22:33
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance 2025-03-05 21:32
1 25 26 27 28 29 264